Engineered non-invasive functionalized dendrimer/dendron-entrapped/complexed gold nanoparticles as a novel class of theranostic (radio)pharmaceuticals in cancer therapy
- 1 April 2021
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 332, 346-366
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Prostate stem cell antigen-targeted nanoparticles with dual functional properties: in vivo imaging and cancer chemotherapyInternational Journal of Nanomedicine, 2012
- Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral ActivityPLOS ONE, 2010
- Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?Journal of Nanoparticle Research, 2010
- Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugateChemical Communications, 2010
- Dendrimer-based tumor cell targeting of fibroblast growth factor-1Bioorganic & Medicinal Chemistry Letters, 2010
- Biodistribution of gadolinium‐based contrast agents, including gadolinium depositionJournal of Magnetic Resonance Imaging, 2009
- Magnetic nanoparticles for theragnosticsAdvanced Drug Delivery Reviews, 2009
- Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesisProceedings of the National Academy of Sciences, 2009
- Targeted Single-Wall Carbon Nanotube-Mediated Pt(IV) Prodrug Delivery Using Folate as a Homing DeviceJournal of the American Chemical Society, 2008
- Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapyNanomedicine: Nanotechnology, Biology and Medicine, 2008